Michael A. Scriven v. VitalCore Health Strategies, LLC (named as “Vital Core, LLC”), et al.

CourtDistrict Court, D. Kansas
DecidedMay 20, 2026
Docket5:22-cv-03282
StatusUnknown

This text of Michael A. Scriven v. VitalCore Health Strategies, LLC (named as “Vital Core, LLC”), et al. (Michael A. Scriven v. VitalCore Health Strategies, LLC (named as “Vital Core, LLC”), et al.) is published on Counsel Stack Legal Research, covering District Court, D. Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Michael A. Scriven v. VitalCore Health Strategies, LLC (named as “Vital Core, LLC”), et al., (D. Kan. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS

MICHAEL A. SCRIVEN,

Plaintiff,

vs. Case No. 22-3282-EFM-RES

VITALCORE HEALTH STRATEGIES, LLC (named as “Vital Core, LLC”), et al.,

Defendants.

MEMORANDUM AND ORDER

Pro se Plaintiff Michael Scriven brings this action against Defendants VitalCore Health Strategies, LLC (incorrectly named as “Vital Core LLC”), Jennifer Ehrlich, Tracy Staley, Dr. Harold Stopp, Ryan Fickle, and Dr. John Tomarchio (incorrectly named as “Demarco”) for alleged violations of his constitutional rights while in custody at the Sedgwick County Jail (“SCJ”). Specifically, Plaintiff asserts that Defendants violated his Fourteenth Amendment rights when they denied him narcotic pain medication for his chronic health conditions. This matter comes before the Court on Defendants’ Motion for Summary Judgment (Doc. 130) and Plaintiff’s Motion to Declare Defendants’ Expert Report Inadmissible (Doc. 147).1 For the following reasons, the Court

1 Plaintiff filed a second Motion to Declare Defendants’ Expert Report Inadmissible at Doc. 155. However, this second motion appears to be a typed copy of the Motion to Declare Defendant’s Expert Report Inadmissible at Doc. 147. Thus, the Court will address these motions as one. grants Defendants’ Motion for Summary Judgment and denies Plaintiff’s Motion to Declare Defendants’ Expert Report Inadmissible. I. Factual and Procedural Background2 A. Plaintiff’s Medical Care for His Chronic Conditions Plaintiff was incarcerated in SCJ as a pretrial detainee in October 2020. He suffers from a

number of chronic health conditions, including: (1) a prosthetic pelvis; (2) plates in his right and left acetabulum; (3) a rod in his right femur; (4) plates in his right rib; (5) a traumatic brain injury; (6) neuropathy/paralysis; (7) tendinopathy; (8) arthritis; (9) severe joint degenerative disease; (10) dystrophic calcification; and (11) heterotropic ossification. Not all of Plaintiff’s conditions were diagnosed before he was incarcerated. Some were the result of Plaintiff’s altercations with other inmates at SCJ. From the time of his incarceration through August 2021, Plaintiff tried several different pain medications for his health conditions. Plaintiff, however, repeatedly complained about his pain, and so on August 16, 2021, Defendant Dr. Stopp prescribed him tramadol. In November

2021, one of Plaintiff’s healthcare providers, Travis Nickelson, documented that Plaintiff was experiencing soft tissue calcification disease. He consulted with Dr. Stopp and both agreed that Plaintiff’s tramadol prescription should be increased to three times a day. Plaintiff was subsequently sent to outside orthopedic specialists, one of whom increased Plaintiff’s dosage of tramadol from 50 mg to 100 mg three times a day. Nickelson approved the specialist’s

2 In accordance with summary judgment procedure, the facts are set forth in the light most favorable to the nonmoving party. recommendation. Thus, at the time of the events at issue here, Plaintiff was receiving the increased dosage of tramadol three times a day. In July 2022, Defendant VitalCore became the medical provider for SCJ. Plaintiff continued to receive tramadol until September 6, 2022, when he was taken off the medication and offered Tylenol and ibuprofen instead. Plaintiff complained to Defendant Tracey Staley, an

advanced practice registered nurse for VitalCore, about the effect of stopping the medication on his health and the fact that NSAIDs, such as ibuprofen, hurt his stomach. That same day, Nurse Staley consulted with Dr. Stopp and Defendant Ryan Fickle, the Health Services Administrator for VitalCore. They agreed that Plaintiff should stop taking tramadol but that he should be tapered off the medicine to decrease withdrawal side effects. Nurse Staley then offered Plaintiff Tylenol and ibuprofen with famotidine to prevent any gastrointestinal issues. On or about September 22, 2022, Plaintiff met with Defendant Ehrlich, Senior Vice President of Operations for VitalCore, and Defendant Dr. Tomarchio, Assistant Chief Medical Officer for VitalCore. They explained why he was being taken off tramadol. Specifically, they

described the effects of opioids on dopamine receptors in the brain and their impact on individuals with a history of substance abuse, especially when taken long-term. Plaintiff was previously treated for substance abuse due to the use of cocaine and methamphetamines. Unwilling to accept their reasoning, Plaintiff became argumentative and insisted he be allowed tramadol for pain management. Instead of acquiescing to Plaintiff’s demands, Ehrlich and Dr. Tomarchio told Plaintiff that they would discuss adding a muscle relaxer for his muscle spasms with Plaintiff’s provider. Plaintiff continued to complain about his lack of tramadol in November 2022. On November 8, 2022, Nurse Staley met with Plaintiff to discuss possible bone growth into his rectum and Plaintiff’s continued requests for tramadol. Nurse Staley’s notes from that meeting state that Plaintiff refuses to take NSAIDs, Tylenol, or famotidine because they are not effective and hurt his liver or kidneys. She noted, however, that Plaintiff’s labs did not indicate a liver or kidney injury. She also noted that Plaintiff refused to take Cymbalta or nortriptyline because he was previously informed it would cause side effects on his traumatic brain injury. Again, however, there was no

evidence of this in Plaintiff’s record. Nurse Staley reminded Plaintiff of “company policy, provider’s right not to prescribe opioids, his pre-disposition to substance abuse and Dr. Tomerchio [sic] recommendations.” She further noted that Plaintiff was prescribed alternative evidence-based care for his pain, but he continues to refuse medication with “no objective findings for contraindication.” Nurse Staley met with Plaintiff again on November 15, 2022. Her notes regarding that meeting indicate that she had been discussing therapeutic options with Dr. Tomarchio, and she conveyed these options to Plaintiff. She also offered Plaintiff an alternative anti-depressant, Effexor, which he declined. Plaintiff continued to decline ibuprofen and famotidine, asserting that

the famotidine caused bloating and discomfort. Plaintiff agreed to try Celebrex on a trial basis. In January 2023, Dr. Curt Meinecke became Plaintiff’s medical provider and authorized a new tramadol prescription. Plaintiff continued to receive tramadol from Dr. Meinecke until he was transferred to state prison in April 2025. B. The Litigation Plaintiff filed this suit on October 31, 2022. He asserts a claim under 42 U.S.C. § 1983 for violation of his Fourteenth Amendment rights. He alleges that Defendants were deliberately indifferent to his serious medical needs when they refused to fill his tramadol prescription in favor of other less efficacious pain medications. He sues Defendant Nurse Staley in her official capacity and Defendants Ehrlich, Dr. Tomarchio, Dr. Stopp and Fickle in their individual capacities. Plaintiff also asserts a Monell3 claim against Defendant VitalCore, which alleges that VitalCore implemented a policy prohibiting inmates at SCJ from receiving narcotic pain medication. During discovery, Defendants retained Dr. Thomas Fowlkes to provide an opinion regarding the medical necessity of the care and treatment requested by Plaintiff. Dr. Fowlkes

opined: In summary, each of these providers used appropriate professional medical judgment to formulate a treatment plan for a difficult patient with chronic pain syndrome who did not have any pathology that could be reversed with surgery or other intervention. Plaintiff was not going to be cured of his heterotopic ossification or the other consequences of his prior traumas.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
Helling v. McKinney
509 U.S. 25 (Supreme Court, 1993)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Berry v. Peterman
604 F.3d 435 (Seventh Circuit, 2010)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Green v. Branson
108 F.3d 1296 (Tenth Circuit, 1997)
Adler v. Wal-Mart Stores, Inc.
144 F.3d 664 (Tenth Circuit, 1998)
Mitchell v. Gencorp Inc.
165 F.3d 778 (Tenth Circuit, 1999)
Dodds v. Richardson
614 F.3d 1185 (Tenth Circuit, 2010)
Goebel v. Denver & Rio Grande Western Railroad
215 F.3d 1083 (Tenth Circuit, 2000)
Sealock v. State Of Colorado
218 F.3d 1205 (Tenth Circuit, 2000)
Mitchell v. City of Moore
218 F.3d 1190 (Tenth Circuit, 2000)
Thompson v. Gibson
289 F.3d 1218 (Tenth Circuit, 2002)
Thom v. Bristol-Myers Squibb Co.
353 F.3d 848 (Tenth Circuit, 2003)
Lifewise Master Funding v. Telebank
374 F.3d 917 (Tenth Circuit, 2004)
Mata v. Saiz
427 F.3d 745 (Tenth Circuit, 2005)
Martinez v. Garden
430 F.3d 1302 (Tenth Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Michael A. Scriven v. VitalCore Health Strategies, LLC (named as “Vital Core, LLC”), et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/michael-a-scriven-v-vitalcore-health-strategies-llc-named-as-vital-ksd-2026.